Dutch biotech startup Scope Biosciences raises €500K to develop, commercialise agricultural diagnostics with CRISPR-Cas-based tech

Scope Biosciences is a startup developing CRISPR-Cas based molecular diagnostics. Here are details of Scope Biosciences’ latest funding round :

🚀 Launch


🏭 Industry



Niek Savelkoul (CEO), Jurre Steens (CTO)

💸 Funding & Investors

INVESTMENT (October 2023)€500,000
INVESTORS (October 2023)led by SHIFT Invest’s Thematic Technology Transfer fund and OostNL.

🎯 Funding purpose

Develop, launch, and commercialise agricultural tests using the innovative scopeDx molecular diagnostic platform.

🌐 Country HQ

The Netherlands (Wageningen)

Leave a Reply

Your email address will not be published.